Japanese market recovery continues in second quarter
This article was originally published in Scrip
Executive Summary
Japan's market for prescription drugs grew by a solid 6% to ¥2,175.1 billion ($23.46 billion) at reimbursement prices in the three months to June 30th, helped by the absence of a general price cut and strong sales of oncology products.